Taha Qazi, MD: AGA Guideline’s Impact on Pouchitis, Inflammatory Pouch Disorder Management


Qazi discusses the impact of having standardized definitions and treatment approaches for pouchitis and inflammatory conditions of the pouch.

Although most patients who undergo colectomy for ulcerative colitis have good long-term functional outcomes, complications can occur, the most common of which is pouchitis or an inflammatory pouch disorder.

The fifth issue of Qazi Corner, a collaborative quarterly newsletter on gastroenterology research, news, and trends between HCPLive and editor-in-chief Taha Qazi, MD, spotlights the management of these patients with a review of the American Gastroenterological Association Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.

“Most of our patients do quite well after surgery. Unfortunately, there is a rising incidence of pouch-based inflammatory disorders,” Qazi, a gastroenterologist with the Cleveland Clinic, explained in an interview with HCPLive, highlighting the “sparse” and “limited” data available to guide the management of these patients because there are not many of them.

Whereas there had previously been what Qazi described as “amorphousness” around definitions pertaining to pouchitis and inflammatory conditions of the pouch, he noted the guideline provides clinicians with a better understanding of how to manage pouch inflammation with standardized guidance that they previously did not have. Specifically, Qazi called attention to the additional context the guideline offers as well as the investigators’ emphasis on the “continuum” of inflammatory diseases encompassed in this topic.

“I think this provides us with an algorithmic understanding of how to manage a pouch inflammation. It was something that I truly enjoyed reading and reviewing because I think it does provide us with a bit more context on the management of pouch inflammatory disorders as we move forward,” he said, adding that the availability of standardized definitions to use in clinical practice will allow for the use of standardized therapies to better gauge response and non-response from patients.

Additionally, he concluded with forward-looking perspective about how this guideline may aid future research by providing clear definitions and treatment goals, something that had previously hindered the understanding of pouchitis.

Related Videos
Kelley Branch, MD, MSc | Credit: University of Washington Medicine
Sejal Shah, MD | Credit: Brigham and Women's
Video 2 - "Differentiating Medication Non-Adherence From Underlying Comorbidities"
Video 1 - "Defining Resistant Diabetes"
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
© 2024 MJH Life Sciences

All rights reserved.